Health Trials

Turning Ratios Into Prognosis: Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Powerful Predictors of ARDS in Pediatric Burn Patients: A Prospective Evaluation

ConditionAcute Respiratory Distress Syndrome (ARDS)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-12
SponsorAin Shams University

About this trial

The aim of this study is to evaluate the role of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as predictors for development of ARDS in pediatric burn patients.

Eligibility criteria

Qualifiers

Age 1-12 years.

Patients presenting within 24 hours of burn injury.

Patients presenting with severe burns 20-40% of total body surface area (TBSA).

Thermal burns or scalds.

Disqualifiers

Patient refusal to participate in the trial.

Age <1 & >12 years.

Delayed admission >24h post-injury.

Patients presenting with burns <20% or >40% of TBSA.

Trial design

Treatments tested in this trial

  • Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios

Treatment groups

No treatment groups listed

Sponsors and collaborators

Ain Shams University

Lead sponsor

Source ClinicalTrials.gov